Showing 2961-2970 of 20895 results for "".
- Allergan Aesthetics Unveiling New AA Signature Program, Immersive Booth at IMCAS World Congress 2025https://reachmd.com/news/allergan-aesthetics-unveiling-new-aa-signature-program-immersive-booth-at-imcas-world-congress-2025/2473731/Allergan Aesthetics, an AbbVie company, is elevating the patient journey with the launch of its news AA Signature Program at the International Master Course of Aging Science (IMCAS) World Congress 2025 in Paris from January 31 through February 1. The new AA Signature Program will provide
- IgE Identified as Key Mediator in Psoriasis and Atherosclerosis Comorbidityhttps://reachmd.com/news/ige-identified-as-key-mediator-in-psoriasis-and-atherosclerosis-comorbidity/2471009/A new review points to immunoglobulin E (IgE) as a potential central player in the overlapping mechanisms of psoriasis and atherosclerosis. Researchers writing in Biomedicine and Pharmacotherapy proposed IgE-mediated mast cell (MC) activation as a significant contributor to the progressio
- Episiotomy Rate Decline in France: No Spike in Anal Sphincter Injurieshttps://reachmd.com/news/episiotomy-rate-decline-in-france-no-spike-in-anal-sphincter-injuries/2471003/What's New A recent study conducted in France shows a dramatic decrease in episiotomy procedures over a decade, with no corresponding rise in obstetric anal sphincter injuries, challenging previous notions about the necessity of episiotomies. Significance
- The Impact of Early Exposure to Television Violence on Adolescentshttps://reachmd.com/news/the-impact-of-early-exposure-to-television-violence-on-adolescents/2471004/What's New A recent study explores the long-term effects of violent television exposure in early childhood, emphasizing its impact on antisocial behavior in adolescence, particularly among boys. Significance This study is significant for healthcare p
- Exploring the Dual Impact of GLP-1 Receptor Agonists: Cognitive Gains and Renal Concernshttps://reachmd.com/news/exploring-the-dual-impact-of-glp-1-receptor-agonists-cognitive-gains-and-renal-concerns/2470996/What's New A new study highlights the dual effects of GLP-1 receptor agonists, showing cognitive benefits and potential kidney risks. Significance Understanding the multifaceted effects of GLP-1 receptor agonists is crucial for informed healthcare de
- Innovative Use of Transgenic Fungi in Malaria Controlhttps://reachmd.com/news/innovative-use-of-transgenic-fungi-in-malaria-control/2470993/What's New A groundbreaking study reveals the potential of genetically modified fungi spread through mosquito mating to combat malaria, offering a novel approach to target elusive outdoor mosquito populations. Significance This innovative approach ad
- Telehealth Utilization Trends: Recent Increases and Regional Variationshttps://reachmd.com/news/telehealth-utilization-trends-recent-increases-and-regional-variations/2470973/Quick Summary Telehealth utilization has increased nationally, with notable exceptions, such as the Midwest. This report highlights which specialties and age demographics are contributing most to the rise. Growth of Telehealth Nationally Most U.S. re
- The Impact of Neighborhood Violence on Adolescent Substance Usehttps://reachmd.com/news/the-impact-of-neighborhood-violence-on-adolescent-substance-use/2470972/Quick Summary A recent study investigated the effects of neighborhood violence on the initiation of alcohol and tobacco use among Latino and African American adolescents. It emphasizes the importance of considering environmental factors beyond individual and peer in
- Linking Gut Inflammation to Psoriasis: New Insightshttps://reachmd.com/news/linking-gut-inflammation-to-psoriasis-new-insights/2470977/What's New A recent study from Uppsala University reveals that psoriasis patients may suffer from hidden gut inflammation, possibly explaining their increased gastrointestinal issues. Significance Understanding the link between skin and gut inflammat
- Study: Safety Signals Emerge for IL-23 and IL-12/23 Inhibitors in Psoriasis Treatmenthttps://reachmd.com/news/safety-signals-emerge-for-il-23-and-il-1223-inhibitors-in-psoriasis-treatment/2470971/A new analysis of psoriasis patients indicates an emergence of new safety signals associated with interleukin-23 (IL-23) inhibitors and the IL-12/23 inhibitor ustekinumab. Researchers on the study analyzed 41.4 million adverse event (AE) reports from the FDA Adverse Event Reporting System